Patents by Inventor Henrik Bengtsson

Henrik Bengtsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190160335
    Abstract: A measurement system for use in an exercise machine, which exercise machine comprises a lifting mechanism and an engaging member for selectively engaging a number of stacked weights to the lifting mechanism, the measurement system comprising a pair of cooperating members including a range meter and a reflector member, wherein one of the cooperating members is connected to the lifting mechanism and the other of the cooperating members is connected to the engaging member, wherein the range meter is directed to measure a distance to the reflector member to determine a distance which correlates to the weight of the selectively engaged weights.
    Type: Application
    Filed: April 13, 2016
    Publication date: May 30, 2019
    Inventors: HENRIK BENGTSSON, JOHAN NYMAN, CHRISTER FLETCHER, MAGNUS LANDQVIST, ANDERS LINGE
  • Publication number: 20190164641
    Abstract: Systems and methods are provided for adjusting a basal/bolus ratio in a standing insulin regimen for a subject that comprises daily amounts of basal and bolus insulin medicaments that define an initial basal/bolus ratio. A data set comprising glucose measurements of the subject with a respective timestamp for each such measurement over a time course is obtained. One or more fasting events are identified in the time course. A temporal glucose gradient is computed for each fasting event using the glucose measurements in the data set within the fasting event time period. Fasting event glucose gradients are used to determine whether to recommend adjustment to the basal/bolus ratio for the subject without change to the daily total insulin medicament. The recommended adjustment to the basal/bolus ratio is communicated when the determination is made to make the recommended adjustment to the basal/bolus ratio for the subject.
    Type: Application
    Filed: August 14, 2017
    Publication date: May 30, 2019
    Inventors: Tinna Bjoerk Aradottir, Henrik Bengtsson, Pete Brockmeier, Jonas Kildegaard Pedersen
  • Patent number: 10300213
    Abstract: The present invention relates to a combined cartridge and needle assembly (10, 15) for use in a re-useable injection device The cartridge (10) containing a pharmaceutical liquid drug and the needle assembly (15) with a needle cannula (25) is permanently attached to each other to form one single unit mountable in the re-usable injection device. The needle assembly (15) is preferably also provided with a spring operated telescopic shield (20) which carries a reservoir (40) containing a cleaning solvent for cleaning at least the distal tip (27) of the needle cannula (25) between injections.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: May 28, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Emil Gram Spork
  • Publication number: 20190156930
    Abstract: Systems and methods are provided for monitoring adherence to an insulin medicament dosage regimen for a subject. A data set comprising a plurality of metabolic events the subject engaged in within a period of time is obtained. Each respective metabolic event comprises a timestamp of the event and a characterization that is one of insulin regimen adherent and insulin regimen nonadherent. A plurality of primary adherence values is calculated, each respective adherence value representing a corresponding time window in a plurality of time windows within the period of time. Each time window is of a same first fixed duration. Each respective adherence value is computed by dividing a number of insulin regimen adherent events by a total number of events that have timestamps in the time window corresponding to the respective adherence value. The adherence values across the period of time are communicated thereby monitoring adherence to the insulin regimen.
    Type: Application
    Filed: June 22, 2017
    Publication date: May 23, 2019
    Inventors: Henrik Bengtsson, Tinna Bjoerk Aradottir, Pete Brockmeier
  • Patent number: 10293109
    Abstract: A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: May 21, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Anders Dejgaard, Alan Moses
  • Publication number: 20190147999
    Abstract: Systems and methods are provided for adjusting long acting insulin medicament dosages for a subject. A plurality of timestamped glucose measurements of the subject and insulin injection data is obtained. A first glycaemic risk measures is determined, where the first risk glycaemic risk measure is i) glucose level variability across the glucose measurements, (ii) a variability in fasting glucose levels calculated from the glucose measurements, (iii) a minimum observed glucose measurement in the plurality of glucose measurements (iv) rate of change in ISF, or (v) adherence values. A fasting blood glucose target function is computed based upon at least the first glycaemic risk measure thereby obtaining an updated target fasting blood glucose level that is between a minimum and maximum target fasting blood glucose level. The long acting insulin medicament dosage is adjusted based upon the updated target fasting blood glucose level.
    Type: Application
    Filed: June 23, 2017
    Publication date: May 16, 2019
    Inventors: Tinna Bjoerk Aradottir, Henrik Bengtsson, Pete Brockmeier
  • Publication number: 20190131010
    Abstract: Systems and methods for evaluating insulin medicament dosage regimen adherence by a subject are provided. A description of metabolic events the subject engaged in is obtained. Each event comprises a timestamp and a classification that is one of insulin regimen adherent and insulin regimen nonadherent. Events are binned into consecutive time windows on the basis of time to obtain a plurality of subsets. Adherence values are computed. Each adherence value is for a subset and is computed by dividing the insulin regimen adherent events by the total number of events in the subset. Adherence values are combined into a composite value by a process that comprises downweighting a first adherence value, representing a first time window, with respect to a second adherence value, representing a second time window, when the first time window occurs in time before the second time window. The composite value is communicated as a single representation.
    Type: Application
    Filed: June 22, 2017
    Publication date: May 2, 2019
    Inventors: Henrik Bengtsson, Tinna Bjoerk Aradottir, Pete Brockmeier
  • Patent number: 10232121
    Abstract: The present invention relates to an injection device for delivering set doses of a liquid drug to a user. The injection device has a scale drum for displaying the set dose, which scale drum is helically guided in a housing. The scale drum is thus rotational in relation to the housing between a zero position and a set position for displaying the set dose. Further, a needle cannula secured to a hub is mounted in an axially movable manner. The axial movement of the hub is generated by a spring. A blocking mechanism interacting between the scale drum and hub controls the axial movement of the hub such that the needle cannula automatically retracts from the skin of a user in response to the scale drum reaching the zero position.
    Type: Grant
    Filed: March 16, 2015
    Date of Patent: March 19, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Ronan Carroll
  • Patent number: 10194067
    Abstract: Controlling a lifelog camera (10) via a first intrapersonal area network (IAN) (12) associated with a first user (14) includes detecting a second IAN (18) associated with a second user (20) in range of the first IAN (12) and capturing an image of the second user (20) with the lifelog camera (10).
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: January 29, 2019
    Assignee: SONY MOBILE COMMUNICATIONS INC.
    Inventors: Ola Thorn, Henrik Bengtsson
  • Publication number: 20190015694
    Abstract: A weight pin for use with a stacked weight exercise machine includes a handle portion, and a shaft portion extending outwardly from the handle portion. The shaft portion is configured to be removably positioned adjacent to one or more weights of the exercise machine to selectively engage the one or more weights during use of the exercise machine. The weight pin also includes interrogation circuitry arranged relative to the handle portion, the interrogation circuitry configured to read information from the adjacent one or more weights.
    Type: Application
    Filed: January 21, 2016
    Publication date: January 17, 2019
    Inventors: Gunnar Klinghult, Johan Nyman, Anders Linge, Henrik Bengtsson
  • Patent number: 10137237
    Abstract: The present invention relates to a needle arrangement for an injection device. The needle arrangement is made up from needle cannula which is mounted such that a distal part having a distal tip extends in a distal direction. Further, a telescopically movable shield carrying a cleaning chamber surrounds at least the tip of the needle cannula between injections such that the tip of the needle cannula is maintained inside the cleaning chamber between subsequent injections. The cleaning chamber is at least distally provided with a pierceable septum through which the needle cannula penetrates during injections. For guiding the needle cannula during injections a telescopically movable tube is provided. During injections the distal end of the telescopically movable tube at least partly penetrates the distal septum.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: November 27, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Lars Eilertsen
  • Patent number: 10133459
    Abstract: The present disclosure provides for a methods and devices for interaction with one or several users, where each user carries at least one personal communication device which is Body Coupled communication, BCC, enabled. A communication device comprises screen which displays information comprising user interface components and the communication device comprises a BCC enabled selection indication means and the users uses the selection indication means to make selection indications of user interface components.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: November 20, 2018
    Assignee: SONY MOBILE COMMUNICATIONS INC.
    Inventors: Markus Andreasson, Henrik Bengtsson
  • Patent number: 10136314
    Abstract: A system with a wireless communication device and one or more wearable communication devices utilizing Body coupled communication, BCC, technology for managing digital keys to a lock. The key management system comprises a wireless communication device and at least one wearable communication device, for managing digital keys, wherein the wireless communication device and the wearable communication device are Body Coupled Communication, BCC, enabled.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: November 20, 2018
    Assignees: SONY CORPORATION, SONY MOBILE COMMUNICATIONS INC.
    Inventors: Henrik Bengtsson, Aleksandar Rodzevski, Anders Mellqvist, Carl-Johan Weiderstrand
  • Publication number: 20180272070
    Abstract: The present invention relates to a piston washer assembly (100, 100?) for use in a drug delivery device for transferring a distally directed axial force from a piston rod (220) towards a piston (214) of a held cartridge (213). The piston washer assembly (100, 100?) comprises a) a proximal part (110, 110?) adapted for engagement with the distal portion of a piston rod (220), the proximal part (110, 110?) defining a first set of cooperating geometries (115, 115?), and b) a distal part (120, 120?) configured to engage and abut a piston (214) of a held cartridge (213) and to engage the proximal part (110, 110?), wherein the distal part (120, 120?) defines a second set of cooperating geometries (125, 125?) engaging the first set of cooperating geometries (115, 115?). In an initial state of the assembly, the proximal part (110, 110?) and the distal part (120, 120?) are positioned relatively to each other to define an initial axial dimension (H1) for the assembly.
    Type: Application
    Filed: September 30, 2016
    Publication date: September 27, 2018
    Inventor: Henrik Bengtsson
  • Publication number: 20180264203
    Abstract: The present invention provides an injection needle unit (10) comprising: a needle assembly (20) comprising: an injection needle (25) extending along a longitudinal axis and having a distal needle end configured for insertion into a subject and a proximal needle end configured for penetration of a reservoir septum, and a skirt (22) surrounding the proximal needle end and defining a receiving space (28) for reception of a needle mount of a drug delivery device, the skirt (22) comprising a slot (24), and a block structure (32) supported exteriorly of the skirt (22), wherein the block structure (32) is biased towards the longitudinal axis and is capable of radial displacement through the slot (24) from a latched position outside the receiving space (28) to a released position within the receiving space (28).
    Type: Application
    Filed: February 19, 2016
    Publication date: September 20, 2018
    Inventors: Henrik Bengtsson, Emil Gram Spork, Lars Eilertsen
  • Patent number: 10034984
    Abstract: The present invention relates to a needle assembly having a build-in valve (30). The needle assembly is built up from a hub (20) carrying a needle cannula (10) and a telescopically movable shield (40) which axially covers the distal tip (13) of the needle cannula (10) between injections. The valve (30) is operated by the shield (40) and is arranged such that it is closed when the distal tip (13) of the needle cannula (10) is covered by the shield (40) and is opened when the telescopically movable shield (40) has been retracted a specific distance (X) proximally to the distal tip (13) of the distal cannula part (11).
    Type: Grant
    Filed: February 14, 2014
    Date of Patent: July 31, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Lars Eilertsen, Henrik Bengtsson
  • Publication number: 20180177952
    Abstract: The present invention relates to a piston washer (109, 209) for use in a drug delivery device for transferring a distally directed axial force from a piston rod (107, 207) towards a piston (199, 299) of a held cartridge (189, 289). The piston washer (109, 209) defines a proximal surface portion (109a) adapted for engagement with the distal portion of a piston rod (107, 207) and a distal surface portion (109b) configured to engage and abut a piston (199, 299). An axial distance defining device (19a1, 109b1, 109c, 209c) is positioned between the proximal surface portion (109a) and the distal surface portion (109b), wherein the axial distance defining device (19a1, 109b1, 109c, 209c) is configured to be shifted from a first axial compressible state into a second axial non-com pressible state. The invention further relates to a drug delivery device incorporating such piston washer (109, 209).
    Type: Application
    Filed: July 1, 2016
    Publication date: June 28, 2018
    Inventors: Henrik Bengtsson, Ronan Carroll, Soeren Steenfeldt-Jensen, Henning Graaskov, Jan Harald Preuthun, Emil Gram Spork
  • Publication number: 20180161506
    Abstract: The present invention relates to a drug delivery device for expelling a dose of drug from a held cartridge and that defines a distal drug outlet end and an opposite proximal end. The drug delivery device comprises: a distal housing component (110) holding a cartridge (113) comprising a liquid drug and a piston slideable arranged therein in an axial direction, and a proximal housing component (101) housing a dose setting and expelling mechanism comprising a piston rod for exerting a force on the piston of the cartridge (113) in a distal direction for expelling a dose. The distal housing component (110) and the proximal housing component (101) are displaceably arranged in axial direction relative to each other for reducing an axial distance between the piston rod (120) and the piston of the cartridge (113).
    Type: Application
    Filed: July 1, 2016
    Publication date: June 14, 2018
    Inventors: Henrik Bengtsson, Anders Noerbygaard, Ronan Carroll, Emil Gram Spork
  • Publication number: 20180140776
    Abstract: The present invention relates to a method of assembling a drug delivery device which in the assembled state defines a distal housing component (102) that houses a piston equipped cartridge (189), and a proximal housing component (101) that houses a dose setting and expelling mechanism. The method includes the steps of arranging the cartridge (189) in the distal housing component (102), arranging a nut element (140) threadedly engaged with a piston rod (107) in the distal housing component (102), and securing the nut element (140) relative to the distal housing component (102) into a selective one of a series of predetermined relative orientations for obtaining a predetermined axial clearance or abutment between the piston rod (107) and the piston of the cartridge (189). The invention further relates to a drug delivery device assembled according to the method.
    Type: Application
    Filed: July 1, 2016
    Publication date: May 24, 2018
    Applicants: Novo Nordisk A/S, Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Ronan Carroll, Emil Gram Spork
  • Patent number: 9977887
    Abstract: Method for validating a trusted user of an electronic device, which electronic device comprises an input surface, e.g. on a key, dedicated for application of a user finger; a user input data sensor system, including a fingerprint sensor connected to the input surface for detecting user input fingerprint data, and a tremor sensor for detecting user input tremor data; data access to stored user input data corresponding to a trusted user; and a main processor system configured to match detected user input data with stored input data for validation of a trusted user. A triggering algorithm may run in a sub-sensor system, for sensing device handling and comparing sensed device handling with stored data. If the comparison reveals that user input is likely to occur based on the, a command is sent to the main processing system to trigger activation of tremor sensing and matching.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: May 22, 2018
    Assignee: SONY MOBILE COMMUNICATIONS INC.
    Inventors: Henrik Bengtsson, Philip Sandell, Olivier Moliner, Ola Thörn, Erik Westenius, Damjan Stamcar, Alexander Rodzevski